AGP Picks
View all

World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on July 30, 2026

SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET
Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
Plymouth Rock Assurance is the First U.S. Carrier to Offer Home Insurance Quoting Through ChatGPT
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial
NurExone Launches Bioprocess Optimization Initiative to Support Commercial and Clinical Readiness
Core AI Announces Formation of Z Studio to Accelerate Expansion into Vertical AI Applications
Beyond Decoration: Ambius Reveals 2026 Holiday Trends Reimagined as "Experience Investments”
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
Monster Beverage to Report Financial Results  for 2026 Second Quarter on August 6, 2026
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates
Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.